← Open Payments lookup

CHARMAINE GRANT: Open Payments

NPI 1659921625 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,001 in 48 payments from 19 companies in 2025. Trend: 2023 $333 · 2024 $957 · 2025 $1,001

Food & beverage: $988Education: $13
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$139
Celgene Corporation5$135
Novartis Pharmaceuticals Corporation5$98
PFIZER INC.5$92
Daiichi Sankyo Inc.4$86
Incyte Corporation3$67
ARRAY BIOPHARMA INC7$46
Eisai Inc.2$42
Genentech USA, Inc.2$40
GENZYME CORPORATION1$32

Products named: REBLOZYL, SCEMBLIX, BRAFTOVI, Enhertu, JAKAFI, Lenvima, Tecentriq, Vanflyta.

Industry payments across GA — which companies pay providers there.